Qingdao Navid Biotechnology Co.
Latest round
- Angel
Last raised
- Aug 2018
Total raised
- Undisclosed
Investors
- 1
About Qingdao Navid Biotechnology Co.
, Ltd., Ltd. specializes in nucleic acid rapid detection technology., Ltd. specializes in the research and development of nucleic acid rapid detection technology, primarily focusing on point-of-care testing (POCT) solutions. The company’s core offerings include sample release agents, nucleic acid extraction reagents, disposable virus sampling tubes, and detection kits for various pathogens, including those responsible for food safety, animal health, and medical diagnostics. Their flagship products leverage a unique isothermal nucleic acid detection technology, which allows for rapid and simplified testing processes, making them suitable for diverse applications including in vitro diagnostics, agricultural safety, and aquaculture. Target customers encompass a broad spectrum of industries, including academic and scientific research institutions, food safety regulators, healthcare providers, and animal husbandry sectors., Ltd. generates revenue through direct sales of its diversified product portfolio, primarily to businesses and institutions engaged in healthcare, food safety, and animal husbandry. The company operates under a direct-to-consumer model, providing its advanced POCT products and supporting instruments directly to end-users and institutional clients. Transactions typically involve bulk orders, with clients purchasing the products based on specific needs for testing and detection. The pricing structure reflects the technological advancement and efficacy of their products, catering to various clients such as hospitals, universities, and agricultural enterprises., Ltd. Additionally, Qingdao Navid aims to expand its market presence in Southeast Asia and Europe by the end of 2023, targeting regions with growing demands for advanced molecular diagnostics.
Who invested in Qingdao Navid Biotechnology Co.
1 investor across 1 round
See all investors in Qingdao Navid Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Aug 14, 2018
Amount
Undisclosed
Investors
Questions about Qingdao Navid Biotechnology Co.
Who invested in Qingdao Navid Biotechnology Co.?
Qingdao Navid Biotechnology Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qingdao Navid Biotechnology Co. raised?
Qingdao Navid Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Qingdao Navid Biotechnology Co. last raise money?
Qingdao Navid Biotechnology Co.'s most recent round on record is a Angel, in Aug 2018.
What does Qingdao Navid Biotechnology Co. do?
Qingdao Navid Biotechnology Co. is a biotechnology company.
Where is Qingdao Navid Biotechnology Co. headquartered?
Qingdao Navid Biotechnology Co. is headquartered in Qingdao, China.
Which VCs invest in companies like Qingdao Navid Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Qingdao Navid Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Qingdao Navid Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.